Expertise

Oodaye Shukla

Chief Data and Analytics Officer

EVERSANA

Oodaye Shukla

Oodaye Shukla serves as EVERSANA’s Chief Data and Analytics Officer. His broad experience in such industries as health care, telecom, the U.S. Department of Defense, and U.S. intelligence Community, spans more than 20 years. Oodaye started his career at the Johns Hopkins Applied Physics Lab, building optical and digital computers and developing neural network models to objectively assess cataract severity. In previous positions at Lucent Technology and Siemens Telecom, Oodaye worked on semiconductor lasers and receivers, 1.6 TB/s optical long-haul systems, and was responsible for a $20 million product portfolio. He joined Lockheed Martin (which later became Vencore) in 2004, to manage the development of a large-scale satellite communications simulation model. Oodaye spearheaded the first efforts in finding undiagnosed rare disease patients, which led to the formation of HVH Precision Analytics, now an EVERSANA company.

Oodaye earned a bachelor’s degree in electrical engineering from The Pennsylvania State University; a master’s degree in electrical engineering (optical signal processing) from The John Hopkins University; a master’s degree in electrical engineering (neural networks) from the University of Maryland; and master’s degree in Technology Management from the University of Pennsylvania/The Wharton School.

Expertise:

Artificial Intelligence (AI), Data & Analytics, Data Science, Patient Journey, Patients, Rare Disease

Articles by Oodaye Shukla

The Evolving World of Artificial Intelligence: Rare Disease Impact

In his latest white paper, Oodaye Shukla, EVERSANA’s Chief Data and Analytics Officer, outlines the revolutionary impact that artificial intelligence and machine learning can have on improving patient outcomes and access to therapy. Rare disease statistics: The average time to get an accurate rare diagnosis is 6-8 years. There are 7,000 distinct types of rare […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.